Publications:430
Mount Sinai DoctorsGirish N Nadkarni, MD
Nephrology
No Patient Experience Ratings
About Me
Girish N. Nadkarni, MD, MPH, is the Irene and Dr. Arthur M. Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai. As an expert physician-scientist, Dr. Nadkarni bridges the gap between comprehensive clinical care and innovative research. He is the System Chief of the Division of Data Driven and Digital Medicine (D3M), the Co-Director of the Mount Sinai Clinical Intelligence Center (MSCIC) and the Director of Charles Bronfman Institute for Personalized Medicine.
Before completing his medical degree at one of the top-ranked medical colleges in India, Dr. Nadkarni received training in mathematics. He then received a master’s degree in public health at the Johns Hopkins Bloomberg School of Public Health, and then was a research associate at the Johns Hopkins Medical Institute. Dr. Nadkarni completed his residency in internal medicine and his clinical fellowship in nephrology at the Icahn School of Medicine at Mount Sinai. He then completed a research fellowship in personalized medicine and informatics.
Dr. Nadkarni has authored more than 240 peer-reviewed scientific publications, including articles in the New England Journal of Medicine, the Journal of the American Medical Association, the Annals of Internal Medicine and Nature Medicine. Dr. Nadkarni is the principal or co-investigator for several grants funded by the National Institutes of Health focusing on informatics, data science, and precision medicine. He is also one of the multiple principal investigators of the NIH RECOVER consortium focusing on the long-term sequelae of COVID-19. He has several patents and is also the scientific co-founder of investor-backed companies—one of which, Renalytix, is listed on NASDAQ. In recognition of his work as an active clinician and investigator, he has received several awards and honors, including the Dr. Harold and Golden Lamport Research Award, the Deal of the Year award from Mount Sinai Innovation Partners, the Carl Nacht Memorial Lecture, and the Rising Star Award from ANIO.
Learn more about Kidney Health in Dr. Nadkarni's Metro.us article.
Learn more about Dr. Nadkarni's work in the Mount Sinai Newsroom.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Research Topics
Bioinformatics, Biostatistics, Cardiovascular, Genetics, Mathematical and Computational Biology, SARS Virus
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS], Immunology [IMM], Neuroscience [NEU]
About Me
Girish N. Nadkarni, MD, MPH, is the Irene and Dr. Arthur M. Fishberg Professor of Medicine at the Icahn School of Medicine at Mount Sinai. As an expert physician-scientist, Dr. Nadkarni bridges the gap between comprehensive clinical care and innovative research. He is the System Chief of the Division of Data Driven and Digital Medicine (D3M), the Co-Director of the Mount Sinai Clinical Intelligence Center (MSCIC) and the Director of Charles Bronfman Institute for Personalized Medicine.
Before completing his medical degree at one of the top-ranked medical colleges in India, Dr. Nadkarni received training in mathematics. He then received a master’s degree in public health at the Johns Hopkins Bloomberg School of Public Health, and then was a research associate at the Johns Hopkins Medical Institute. Dr. Nadkarni completed his residency in internal medicine and his clinical fellowship in nephrology at the Icahn School of Medicine at Mount Sinai. He then completed a research fellowship in personalized medicine and informatics.
Dr. Nadkarni has authored more than 240 peer-reviewed scientific publications, including articles in the New England Journal of Medicine, the Journal of the American Medical Association, the Annals of Internal Medicine and Nature Medicine. Dr. Nadkarni is the principal or co-investigator for several grants funded by the National Institutes of Health focusing on informatics, data science, and precision medicine. He is also one of the multiple principal investigators of the NIH RECOVER consortium focusing on the long-term sequelae of COVID-19. He has several patents and is also the scientific co-founder of investor-backed companies—one of which, Renalytix, is listed on NASDAQ. In recognition of his work as an active clinician and investigator, he has received several awards and honors, including the Dr. Harold and Golden Lamport Research Award, the Deal of the Year award from Mount Sinai Innovation Partners, the Carl Nacht Memorial Lecture, and the Rising Star Award from ANIO.
Learn more about Kidney Health in Dr. Nadkarni's Metro.us article.
Learn more about Dr. Nadkarni's work in the Mount Sinai Newsroom.
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Research Topics
Bioinformatics, Biostatistics, Cardiovascular, Genetics, Mathematical and Computational Biology, SARS Virus
Multi-Disciplinary Training Areas
Artificial Intelligence and Emerging Technologies in Medicine [AIET], Genetics and Genomic Sciences [GGS], Immunology [IMM], Neuroscience [NEU]